Clinical Trials
73
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (65 trials with phase data)• Click on a phase to view related trials
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
- Conditions
- Type 1 Diabetes MellitisType 2 Diabetes Mellitus
- First Posted Date
- 2025-11-14
- Last Posted Date
- 2025-11-14
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 400
- Registration Number
- NCT07228117
- Locations
- 🇺🇸
Medical Investigations, Little Rock, Arkansas, United States
🇺🇸Headlands Research California, LLC, Escondido, California, United States
🇺🇸Sansum Diabetes Research Institute, Goleta, California, United States
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
- Conditions
- Diabetes (Insulin-requiring, Type 1 or Type 2)
- First Posted Date
- 2025-11-13
- Last Posted Date
- 2025-11-13
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 116
- Registration Number
- NCT07227805
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
- Conditions
- Type I Diabetes
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-11-10
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 40
- Registration Number
- NCT06739811
- Locations
- 🇫🇷
Hôpital Européen Marseille, Marseille, France
🇫🇷Centre Hospitalier Universitaire De Montpellier, Montpellier, France, France
🇳🇱Isala Zwolle, Zwolle, Netherlands, Netherlands
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Conditions
- Type 1 Diabetes MellitusType 2 Diabetes Mellitus
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 1500
- Registration Number
- NCT06719531
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸ProSciento, Chula Vista, California, United States
🇺🇸John Muir Health, Concord, California, United States
Smart MDI Study (CIP343)
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 179
- Registration Number
- NCT06645834
- Locations
- 🇧🇪
Antwerp University Hospital, Antwerpen, Belgium
🇧🇪Hospital Universitaire Bruxelles Erasme, Brussels, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next